Literature DB >> 22487531

Living in dressings and bandages: findings from workshops with people with Epidermolysis bullosa.

Patricia Grocott1, Rebecca Blackwell, Heather Weir, Elizabeth Pillay.   

Abstract

Epidermolysis bullosa (EB) is an inherited disorder causing extensive, painful skin blistering and wounds. Currently, there is no cure and the focus of care is on the clinical management of the skin and other affected body systems, together with supportive care to individuals and families. The wound care for Epidermolysis bullosa (WEB) project is a collaboration with adults with EB, carers, clinical nurse specialists, a designer and manufacturers to develop novel products for EB wound care. This article reports the findings from workshops with adults with EB, their carers and clinical nurse specialists, together with observations of dressing changes. A cluster of significant limitations were revealed in the performance of wound care products, designed to cover a single wound, when they are used to cover extensive and whole body wounds. A working hypothesis for EB wound care was developed from the findings, together with design concepts and new products for EB wound care. In addition, a model of user engagement in medical device development and evaluation has been tested.
© 2012 The Authors. International Wound Journal © 2012 John Wiley & Sons Ltd and Medicalhelplines.com Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22487531      PMCID: PMC7950808          DOI: 10.1111/j.1742-481X.2012.00973.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  17 in total

1.  Clinical evaluation of a new, above-elbow, body-powered prosthetic arm: a final report.

Authors:  M E Cupo; S J Sheredos
Journal:  J Rehabil Res Dev       Date:  1998-10

2.  The iterative use of economic evaluation as part of the process of health technology assessment.

Authors:  M Sculpher; M Drummond; M Buxton
Journal:  J Health Serv Res Policy       Date:  1997-01

3.  A model of user engagement in medical device development.

Authors:  Patricia Grocott; Heather Weir; Mala Bridgelal Ram
Journal:  Int J Health Care Qual Assur       Date:  2007

4.  Validity, trustworthiness and rigour: reasserting realism in qualitative research.

Authors:  Sam Porter
Journal:  J Adv Nurs       Date:  2007-10       Impact factor: 3.187

5.  Issues and challenges of involving users in medical device development.

Authors:  Mala Bridgelal Ram; Patricia R Grocott; Heather C M Weir
Journal:  Health Expect       Date:  2008-03       Impact factor: 3.377

6.  Disconnection: the user voice within the wound dressing supply chain.

Authors:  Natasha Campling; Patricia Grocott; Sarah Cowley
Journal:  J Nurs Manag       Date:  2008-03       Impact factor: 3.325

Review 7.  Recessive dystrophic epidermolysis bullosa. Part 2: care of the adult patient.

Authors:  Elizabeth M Abercrombie; Claire A Mather; Jennie Hon; Pauline Graham-King; Elizabeth Pillay
Journal:  Br J Nurs       Date:  2008 Mar 27-Apr 9

Review 8.  Collecting and analysing qualitative data: issues raised by the focus group.

Authors:  J Sim
Journal:  J Adv Nurs       Date:  1998-08       Impact factor: 3.187

9.  Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis.

Authors:  A W M Evers; Y Lu; P Duller; P G M van der Valk; F W Kraaimaat; P C M van de Kerkhof
Journal:  Br J Dermatol       Date:  2005-06       Impact factor: 9.302

10.  Service user involvement in cancer care: the impact on service users.

Authors:  Phil Cotterell; Gwen Harlow; Carolyn Morris; Peter Beresford; Bec Hanley; Anita Sargeant; John Sitzia; Kristina Staley
Journal:  Health Expect       Date:  2010-10-28       Impact factor: 3.377

View more
  9 in total

1.  Preliminary evaluation of cord blood platelet gel for the treatment of skin lesions in children with dystrophic epidermolysis bullosa.

Authors:  Gianluca Tadini; Sophie Guez; Lidia Pezzani; Maurizio Marconi; Noemi Greppi; Francesca Manzoni; Paolo Rebulla; Susanna Esposito
Journal:  Blood Transfus       Date:  2014-10-29       Impact factor: 3.443

Review 2.  Co-producing novel wound care products for Epidermolysis bullosa; an empirical case study of the use of surrogates in the design and prototype development process.

Authors:  Patricia Grocott; Rebecca Blackwell; Conchita Currie; Elizabeth Pillay; Glenn Robert
Journal:  Int Wound J       Date:  2012-04-09       Impact factor: 3.315

3.  Financial burden of epidermolysis bullosa on patients in the United States.

Authors:  Emily S Gorell; Paige W Wolstencroft; Mark P de Souza; Dedee F Murrell; Eleni Linos; Jean Y Tang
Journal:  Pediatr Dermatol       Date:  2020-09-08       Impact factor: 1.588

4.  Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.

Authors:  Aris Angelis; Panos Kanavos; Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; Valentin Brodszky; Johann Matthias Graf von der Schulenburg; Karine Chevreul; Ulf Persson; Giovanni Fattore
Journal:  Eur J Health Econ       Date:  2016-04-23

Review 5.  Occupational therapy for epidermolysis bullosa: clinical practice guidelines.

Authors:  Jennifer M Chan; Amy Weisman; Alex King; Susan Maksomski; Carrissa Shotwell; Claire Bailie; Helen Weaver; Rebecca Bodan; Estrella Guerrero; Matija Zmazek; Phuong Khuu
Journal:  Orphanet J Rare Dis       Date:  2019-06-07       Impact factor: 4.123

6.  A prospective short-term study to evaluate methodologies for the assessment of disease extent, impact, and wound evolution in patients with dystrophic epidermolysis bullosa.

Authors:  Amy S Paller; Elena Pope; Dan Rudin; Anna Malyala; Deborah Ramsdell; Ramsey Johnson; Hal Landy; Dedee F Murrell
Journal:  Orphanet J Rare Dis       Date:  2022-08-13       Impact factor: 4.303

7.  Prioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: where should research direct to? an example of priority setting partnership in very rare disorders.

Authors:  Paula Davila-Seijo; Angela Hernández-Martín; Evanina Morcillo-Makow; Raúl de Lucas; Esther Domínguez; Natividad Romero; Eva Monrós; Marta Feito; Luis Carretero; Bea Aranegui; Ignacio García-Doval
Journal:  Orphanet J Rare Dis       Date:  2013-04-22       Impact factor: 4.123

8.  Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB.

Authors:  Christos Georgiadis; Farhatullah Syed; Anastasia Petrova; Alya Abdul-Wahab; Su M Lwin; Farzin Farzaneh; Lucas Chan; Sumera Ghani; Roland A Fleck; Leanne Glover; James R McMillan; Mei Chen; Adrian J Thrasher; John A McGrath; Wei-Li Di; Waseem Qasim
Journal:  J Invest Dermatol       Date:  2016-01       Impact factor: 8.551

Review 9.  Review of the Latest Methods of Epidermolysis Bullosa and Other Chronic Wounds Treatment Including BIOOPA Dressing.

Authors:  Magdalena Nita; Jacek Pliszczyński; Maciej Kosieradzki; Piotr Fiedor
Journal:  Dermatol Ther (Heidelb)       Date:  2021-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.